Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Newborn calves need to ingest maternal colostrum, which is rich in immunoglobulin G (IgG) content, to help them develop their naïve immune system. This requires calves to ingest high masses of IgG, generally above 100 g in the first hours of life. In addition to feeding high IgG masses to newborn calves, research suggests that low-quality colostrum (<50 g/L IgG) can be enriched with colostrum replacer in order to increase its IgG concentration. Recently, it was reported that enriching maternal colostrum with 30 g/L IgG concentration with colostrum replacer resulted in increased IgG absorption, with none of the calves experiencing failure of passive immune (FPI) transfer. As a result, enriching low-quality colostrum could lead to desirable passive immune transfer rates providing adequate total IgG mass to the calf without compromising its absorption. The enrichment of colostrum with colostrum replacer represents an alternative for dairy farms that produce low-quality colostrum. Thus, enriching low-quality colostrum with colostrum replacer will enable farms to achieve adequate passive immune transfer rates, which will benefit the short-term health of calves, and more importantly, improve long-term health implications by preventing illness early in life.
Michael Steele
Saskatoon Colostrum Company Ltd.
Life Sciences
Manufacturing
University of Guelph
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.